Dr. Cato Laurencin, M.D., Ph.D., was presented the Technology Innovation and Development Award from the Society for Biomaterials. Dr. Laurencin is CEO of the Connecticut Institute for Clinical and Translational Science, Director of the Institute for Regenerative Engineering, the Van Dusen Endowed Chair in Academic Medicine and a professor of Chemical & Biomolecular Engineering. The award recognizes an individual or team who provided key scientific and technical innovation and leadership in a novel product in which biomaterials played an important and enabling role. For more than three decades, Dr. Laurencin has conducted research studies on biomaterials for musculoskeletal tissue engineering, nanotechnology, and drug delivery. He notes that he was influenced by his Ph.D. mentor, Dr. Robert Langer, an Institution Professor at MIT. Read more about Dr. Laurencin here.